Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK-104-CR in Primary Hyperlipidemia or Mixed Dyslipidemia
NCT02670434Phase 3Withdrawn
- Start
- Jan 2016
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
A Phase 3 trial of pitavastatin in hyperlipidemia, dyslipidemia. Planned start Jan 2016; status: withdrawn.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemiadyslipidemia
Beyond the preview
Go deeper on NCT02670434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670434.